Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-20

Clinical Trial Update: OBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs

View source ↗

Summary

An international observational study at Central Hospital, Nancy, France, evaluating antiphospholipid syndrome patients treated with direct oral anticoagulants a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apixaban (apixaban)
  • Dabigatran (Dabigatran etexilate)
  • Edoxaban (edoxaban)
  • Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Antiphospholipid Syndrome (APS), Direct Oral Anticoagulants (DOACs) | Status: NOT_YET_RECRUITING